Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ciaflex F (also known as Cyaplex F) is a plant-based dietary supplement developed by Cellmed Bio, a brand under JBK Lab in South Korea. It is available in multiple oral dosage forms, including granules, syrup, and tablets. The supplement is formulated with antioxidant-rich phytonutrients, typically derived from aronia berries and other botanical sources, which are central to the Cellmed product line. While specific clinical trial data is not publicly detailed, the product is marketed for joint and musculoskeletal support, as suggested by the 'flex' designation in its name. It is manufactured in facilities adhering to HACCP and GMP standards and is distributed primarily through pharmacies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ciaflex F.